- Home
- ECCC vs TALKW Comparison
ECCC vs TALKW Comparison
Compare ECCC & TALKW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECCC
- TALKW
- Stock Information
- Founded
- ECCC N/A
- TALKW N/A
- Country
- ECCC United States
- TALKW United States
- Employees
- ECCC N/A
- TALKW 472
- Industry
- ECCC Trusts Except Educational Religious and Charitable
- TALKW Medical/Nursing Services
- Sector
- ECCC Finance
- TALKW Health Care
- Exchange
- ECCC Nasdaq
- TALKW Nasdaq
- Market Cap
- ECCC N/A
- TALKW N/A
- IPO Year
- ECCC N/A
- TALKW 2020
- Fundamental
- Price
- ECCC $23.10
- TALKW $0.15
- Analyst Decision
- ECCC
- TALKW
- Analyst Count
- ECCC 0
- TALKW 0
- Target Price
- ECCC N/A
- TALKW N/A
- AVG Volume (30 Days)
- ECCC N/A
- TALKW N/A
- Earning Date
- ECCC N/A
- TALKW N/A
- Dividend Yield
- ECCC N/A
- TALKW N/A
- EPS Growth
- ECCC N/A
- TALKW N/A
- EPS
- ECCC N/A
- TALKW N/A
- Revenue
- ECCC N/A
- TALKW N/A
- Revenue This Year
- ECCC N/A
- TALKW N/A
- Revenue Next Year
- ECCC N/A
- TALKW N/A
- P/E Ratio
- ECCC N/A
- TALKW N/A
- Revenue Growth
- ECCC N/A
- TALKW N/A
- 52 Week Low
- ECCC N/A
- TALKW N/A
- 52 Week High
- ECCC N/A
- TALKW N/A
- Technical
- Relative Strength Index (RSI)
- ECCC 52.21
- TALKW N/A
- Support Level
- ECCC $22.79
- TALKW N/A
- Resistance Level
- ECCC $23.00
- TALKW N/A
- Average True Range (ATR)
- ECCC 0.11
- TALKW 0.00
- MACD
- ECCC 0.04
- TALKW 0.00
- Stochastic Oscillator
- ECCC 100.00
- TALKW 0.00
About ECCC Eagle Point Credit Company Inc. 6.50% Series C Term Preferred Stock due 2031
Eagle Point Credit Co Inc is an externally managed, non-diversified closed-end management investment company.
About TALKW Talkspace Inc. Warrant
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue primarily stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.